Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Injuries | 51 | 2024 | 2025 | 5.090 |
Why?
|
Brain Concussion | 16 | 2022 | 1320 | 2.840 |
Why?
|
Urinary Bladder Neoplasms | 9 | 2024 | 2245 | 2.810 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 8 | 2022 | 143 | 2.450 |
Why?
|
Maze Learning | 22 | 2020 | 478 | 2.170 |
Why?
|
Cystectomy | 8 | 2024 | 686 | 1.880 |
Why?
|
Blood-Brain Barrier | 17 | 2020 | 1017 | 1.830 |
Why?
|
Carcinoma, Transitional Cell | 4 | 2024 | 808 | 1.690 |
Why?
|
Recovery of Function | 14 | 2019 | 2925 | 1.510 |
Why?
|
Necrosis | 9 | 2022 | 1643 | 1.330 |
Why?
|
Cell Membrane Permeability | 5 | 2020 | 590 | 1.230 |
Why?
|
Cell Death | 13 | 2022 | 1706 | 1.060 |
Why?
|
Brain Edema | 10 | 2014 | 617 | 1.050 |
Why?
|
Disease Models, Animal | 32 | 2024 | 18029 | 1.020 |
Why?
|
Head Injuries, Closed | 7 | 2022 | 136 | 1.010 |
Why?
|
Cerebral Cortex | 18 | 2024 | 5708 | 1.000 |
Why?
|
Hippocampus | 9 | 2021 | 3675 | 0.950 |
Why?
|
Cyanoacrylates | 1 | 2024 | 49 | 0.950 |
Why?
|
Vinyl Compounds | 2 | 2014 | 20 | 0.910 |
Why?
|
Cerebral Hemorrhage | 5 | 2020 | 2647 | 0.870 |
Why?
|
Aspartic Acid Endopeptidases | 3 | 2013 | 311 | 0.840 |
Why?
|
Mice | 73 | 2024 | 81183 | 0.810 |
Why?
|
Search Engine | 1 | 2023 | 144 | 0.800 |
Why?
|
Prostatectomy | 5 | 2023 | 1890 | 0.790 |
Why?
|
Receptors, Interleukin-1 | 2 | 2022 | 262 | 0.790 |
Why?
|
Tauopathies | 2 | 2022 | 307 | 0.780 |
Why?
|
Pyrrolidines | 2 | 2014 | 342 | 0.760 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2014 | 2503 | 0.740 |
Why?
|
Amyloid Precursor Protein Secretases | 3 | 2013 | 584 | 0.720 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2014 | 2109 | 0.710 |
Why?
|
Microglia | 8 | 2023 | 1266 | 0.700 |
Why?
|
Lymphatic Metastasis | 3 | 2024 | 2924 | 0.680 |
Why?
|
Animals | 93 | 2024 | 168757 | 0.660 |
Why?
|
Prostatic Neoplasms | 9 | 2023 | 11124 | 0.640 |
Why?
|
Rhabdomyosarcoma | 1 | 2021 | 382 | 0.640 |
Why?
|
Inflammation | 15 | 2023 | 10638 | 0.600 |
Why?
|
Membranes, Artificial | 1 | 2019 | 378 | 0.590 |
Why?
|
Cognition Disorders | 7 | 2019 | 4043 | 0.580 |
Why?
|
Cryotherapy | 1 | 2017 | 155 | 0.570 |
Why?
|
Mice, Inbred C57BL | 29 | 2023 | 21827 | 0.560 |
Why?
|
Malnutrition | 1 | 2023 | 625 | 0.560 |
Why?
|
Edema | 1 | 2020 | 789 | 0.560 |
Why?
|
Neuroprotective Agents | 4 | 2023 | 941 | 0.550 |
Why?
|
Neuroglia | 3 | 2019 | 927 | 0.550 |
Why?
|
Neurons | 17 | 2020 | 9338 | 0.550 |
Why?
|
Brain | 23 | 2023 | 26385 | 0.520 |
Why?
|
Mice, Knockout | 19 | 2021 | 14557 | 0.520 |
Why?
|
Conditioning, Classical | 2 | 2015 | 366 | 0.520 |
Why?
|
Granulocyte Colony-Stimulating Factor | 3 | 2004 | 648 | 0.490 |
Why?
|
Neoadjuvant Therapy | 3 | 2021 | 2728 | 0.490 |
Why?
|
Protein Kinases | 1 | 2020 | 1640 | 0.450 |
Why?
|
Cerebrum | 1 | 2014 | 137 | 0.450 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9239 | 0.450 |
Why?
|
Middle Cerebral Artery | 1 | 2014 | 264 | 0.440 |
Why?
|
Cognition | 10 | 2024 | 6770 | 0.430 |
Why?
|
Amyloid beta-Protein Precursor | 3 | 2013 | 1121 | 0.430 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1061 | 0.430 |
Why?
|
Intercellular Adhesion Molecule-1 | 4 | 2000 | 1155 | 0.430 |
Why?
|
Cortical Spreading Depression | 3 | 2022 | 276 | 0.420 |
Why?
|
Neutrophils | 12 | 2021 | 3719 | 0.420 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2023 | 4420 | 0.410 |
Why?
|
Cell Membrane | 2 | 2011 | 3748 | 0.410 |
Why?
|
Extinction, Psychological | 1 | 2015 | 376 | 0.400 |
Why?
|
Diabetic Ketoacidosis | 1 | 2014 | 245 | 0.390 |
Why?
|
Male | 76 | 2023 | 350118 | 0.390 |
Why?
|
Annexin A2 | 2 | 2021 | 44 | 0.380 |
Why?
|
Cerebrovascular Circulation | 4 | 2021 | 2731 | 0.380 |
Why?
|
Microcirculation | 1 | 2015 | 1286 | 0.370 |
Why?
|
B-Lymphocytes | 3 | 2023 | 4665 | 0.370 |
Why?
|
Albumins | 2 | 2023 | 569 | 0.360 |
Why?
|
Imidazoles | 3 | 2014 | 1206 | 0.360 |
Why?
|
Parietal Lobe | 1 | 2015 | 838 | 0.350 |
Why?
|
Hand Strength | 5 | 2013 | 448 | 0.350 |
Why?
|
Brachytherapy | 1 | 2017 | 1248 | 0.350 |
Why?
|
Motor Skills | 5 | 2015 | 522 | 0.340 |
Why?
|
Androgen Antagonists | 1 | 2017 | 1377 | 0.330 |
Why?
|
E-Selectin | 3 | 2000 | 579 | 0.320 |
Why?
|
Silk | 2 | 2018 | 91 | 0.320 |
Why?
|
Apoptosis | 5 | 2022 | 9727 | 0.320 |
Why?
|
Immunohistochemistry | 11 | 2017 | 11366 | 0.310 |
Why?
|
Indoles | 3 | 2014 | 1839 | 0.310 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2000 | 440 | 0.300 |
Why?
|
Amyloid beta-Peptides | 4 | 2013 | 3587 | 0.300 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2010 | 595 | 0.300 |
Why?
|
Muscles | 2 | 2023 | 1614 | 0.300 |
Why?
|
Cell Count | 5 | 2019 | 1856 | 0.300 |
Why?
|
Behavior, Animal | 6 | 2020 | 1881 | 0.300 |
Why?
|
Treatment Outcome | 16 | 2024 | 63114 | 0.290 |
Why?
|
Fear | 2 | 2015 | 1440 | 0.290 |
Why?
|
Warfarin | 2 | 2014 | 1496 | 0.290 |
Why?
|
Motor Activity | 5 | 2015 | 2714 | 0.290 |
Why?
|
Mannose-Binding Lectin | 1 | 2008 | 150 | 0.290 |
Why?
|
Hemoglobins | 2 | 2023 | 1534 | 0.290 |
Why?
|
Complement C4 | 1 | 2007 | 257 | 0.280 |
Why?
|
Prostate | 3 | 2023 | 1774 | 0.280 |
Why?
|
Retrospective Studies | 16 | 2024 | 77449 | 0.280 |
Why?
|
Memory | 6 | 2016 | 2174 | 0.280 |
Why?
|
Apolipoprotein E4 | 1 | 2010 | 668 | 0.270 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2006 | 92 | 0.270 |
Why?
|
Intracranial Hemorrhages | 1 | 2012 | 855 | 0.270 |
Why?
|
Meningitis, Bacterial | 3 | 2003 | 218 | 0.270 |
Why?
|
Contusions | 2 | 2023 | 81 | 0.260 |
Why?
|
Urinary Bladder | 2 | 2023 | 1172 | 0.260 |
Why?
|
Dentate Gyrus | 3 | 2016 | 160 | 0.260 |
Why?
|
Propidium | 3 | 2011 | 41 | 0.260 |
Why?
|
Watchful Waiting | 2 | 2021 | 492 | 0.250 |
Why?
|
Lymph Nodes | 3 | 2023 | 3474 | 0.250 |
Why?
|
In Situ Nick-End Labeling | 3 | 2012 | 643 | 0.250 |
Why?
|
Lymphocytes | 2 | 2023 | 2617 | 0.250 |
Why?
|
Medicare | 1 | 2022 | 6566 | 0.250 |
Why?
|
Humans | 65 | 2024 | 744343 | 0.230 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2020 | 1018 | 0.230 |
Why?
|
Macrophages | 4 | 2019 | 5655 | 0.230 |
Why?
|
Nevada | 1 | 2023 | 22 | 0.230 |
Why?
|
Homeostasis | 1 | 2014 | 3340 | 0.230 |
Why?
|
Accidents, Traffic | 2 | 2012 | 819 | 0.220 |
Why?
|
New Mexico | 1 | 2023 | 86 | 0.220 |
Why?
|
Louisiana | 1 | 2023 | 108 | 0.220 |
Why?
|
Alabama | 1 | 2023 | 98 | 0.220 |
Why?
|
Asphyxia | 1 | 2003 | 57 | 0.220 |
Why?
|
Reperfusion Injury | 2 | 2008 | 1026 | 0.220 |
Why?
|
Retinal Hemorrhage | 1 | 2003 | 96 | 0.220 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3479 | 0.210 |
Why?
|
Space Perception | 4 | 2012 | 475 | 0.210 |
Why?
|
Enzyme Inhibitors | 3 | 2011 | 3798 | 0.210 |
Why?
|
Encephalocele | 1 | 2003 | 136 | 0.210 |
Why?
|
Microdialysis | 1 | 2002 | 158 | 0.210 |
Why?
|
Neck Injuries | 1 | 2003 | 152 | 0.200 |
Why?
|
Permeability | 3 | 2011 | 738 | 0.200 |
Why?
|
Signal Transduction | 9 | 2021 | 23403 | 0.200 |
Why?
|
Glutamates | 1 | 2003 | 398 | 0.200 |
Why?
|
Mycoplasma pneumoniae | 1 | 2021 | 43 | 0.200 |
Why?
|
Neisseria meningitidis, Serogroup C | 1 | 2021 | 11 | 0.200 |
Why?
|
Uteroglobin | 1 | 2021 | 58 | 0.200 |
Why?
|
Nephrectomy | 3 | 2016 | 1050 | 0.200 |
Why?
|
Compartment Syndromes | 1 | 2003 | 153 | 0.200 |
Why?
|
Orbital Diseases | 1 | 2003 | 181 | 0.190 |
Why?
|
Integrin alpha4beta1 | 1 | 2021 | 121 | 0.190 |
Why?
|
Pneumonia, Mycoplasma | 1 | 2021 | 50 | 0.190 |
Why?
|
Purpura Fulminans | 1 | 2021 | 22 | 0.190 |
Why?
|
Multiple Organ Failure | 2 | 2021 | 390 | 0.190 |
Why?
|
Neurogenic Inflammation | 2 | 1998 | 33 | 0.190 |
Why?
|
Meningococcal Infections | 1 | 2021 | 77 | 0.190 |
Why?
|
Thoracic Injuries | 1 | 2003 | 272 | 0.190 |
Why?
|
Rats | 11 | 2019 | 24260 | 0.190 |
Why?
|
Neural Stem Cells | 3 | 2016 | 851 | 0.190 |
Why?
|
Injections, Intravenous | 2 | 2014 | 1420 | 0.190 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2000 | 707 | 0.190 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2021 | 188 | 0.180 |
Why?
|
Platelet Count | 1 | 2023 | 781 | 0.180 |
Why?
|
Movement | 1 | 2007 | 1471 | 0.180 |
Why?
|
Vasospasm, Intracranial | 1 | 2002 | 208 | 0.180 |
Why?
|
Encephalitis | 2 | 2008 | 423 | 0.180 |
Why?
|
Leukocytosis | 1 | 2000 | 247 | 0.170 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2019 | 40 | 0.170 |
Why?
|
Acute-Phase Reaction | 1 | 1999 | 91 | 0.170 |
Why?
|
Anticoagulants | 3 | 2021 | 4599 | 0.170 |
Why?
|
Body Temperature | 2 | 2004 | 777 | 0.170 |
Why?
|
Antimetabolites | 1 | 2019 | 125 | 0.170 |
Why?
|
Caspases | 4 | 2011 | 928 | 0.160 |
Why?
|
Brain Tissue Transplantation | 1 | 2018 | 81 | 0.160 |
Why?
|
Deoxyglucose | 1 | 2019 | 337 | 0.160 |
Why?
|
Pneumococcal Infections | 1 | 2003 | 497 | 0.160 |
Why?
|
Tracheomalacia | 1 | 2018 | 63 | 0.160 |
Why?
|
Drug Implants | 1 | 2019 | 244 | 0.160 |
Why?
|
Hyperkinesis | 1 | 2018 | 89 | 0.160 |
Why?
|
Neutropenia | 2 | 2000 | 895 | 0.160 |
Why?
|
Blotting, Western | 4 | 2017 | 5179 | 0.160 |
Why?
|
Brain Chemistry | 4 | 2010 | 981 | 0.160 |
Why?
|
Seminal Vesicles | 1 | 2018 | 101 | 0.160 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2013 | 3870 | 0.160 |
Why?
|
Splints | 1 | 2018 | 111 | 0.160 |
Why?
|
Neurogenesis | 4 | 2017 | 838 | 0.160 |
Why?
|
tau Proteins | 2 | 2021 | 1868 | 0.150 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6364 | 0.150 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2021 | 571 | 0.150 |
Why?
|
P-Selectin | 1 | 2000 | 600 | 0.150 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2015 | 4266 | 0.150 |
Why?
|
Prognosis | 4 | 2023 | 29063 | 0.150 |
Why?
|
Caspase 3 | 3 | 2012 | 758 | 0.150 |
Why?
|
Analysis of Variance | 6 | 2012 | 6365 | 0.150 |
Why?
|
Lymph Node Excision | 1 | 2023 | 1261 | 0.150 |
Why?
|
Inflammasomes | 1 | 2022 | 495 | 0.150 |
Why?
|
Interleukin-8 | 1 | 2000 | 690 | 0.150 |
Why?
|
Coloring Agents | 2 | 2011 | 566 | 0.150 |
Why?
|
Cytarabine | 1 | 2019 | 692 | 0.150 |
Why?
|
Postural Balance | 2 | 2013 | 620 | 0.150 |
Why?
|
Carbon Dioxide | 1 | 2021 | 1150 | 0.140 |
Why?
|
Interleukin-18 | 1 | 2018 | 249 | 0.140 |
Why?
|
Axons | 3 | 2015 | 1684 | 0.140 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4751 | 0.140 |
Why?
|
Neoplasm Invasiveness | 2 | 2021 | 3616 | 0.140 |
Why?
|
Aging | 2 | 2016 | 8664 | 0.140 |
Why?
|
Mice, Inbred Strains | 2 | 2014 | 1827 | 0.140 |
Why?
|
Brain Ischemia | 2 | 2020 | 3265 | 0.130 |
Why?
|
Thrombospondin 1 | 1 | 2017 | 250 | 0.130 |
Why?
|
Craniocerebral Trauma | 1 | 2000 | 482 | 0.130 |
Why?
|
Caspase 8 | 2 | 2016 | 195 | 0.130 |
Why?
|
Mice, Transgenic | 5 | 2019 | 9734 | 0.130 |
Why?
|
Intensive Care Units, Pediatric | 3 | 2012 | 981 | 0.130 |
Why?
|
Interferon-beta | 1 | 2017 | 323 | 0.130 |
Why?
|
Freezing Reaction, Cataleptic | 1 | 2015 | 42 | 0.130 |
Why?
|
Electroshock | 1 | 2015 | 122 | 0.130 |
Why?
|
Calcium Channels, N-Type | 1 | 2015 | 39 | 0.130 |
Why?
|
Glycolysis | 1 | 2019 | 827 | 0.130 |
Why?
|
Psychomotor Performance | 3 | 2010 | 1901 | 0.130 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2915 | 0.130 |
Why?
|
Leukocyte Count | 5 | 2004 | 1588 | 0.130 |
Why?
|
Cells, Cultured | 9 | 2018 | 19229 | 0.130 |
Why?
|
Cell Survival | 5 | 2018 | 5882 | 0.130 |
Why?
|
Fournier Gangrene | 1 | 2014 | 21 | 0.130 |
Why?
|
Phosphorylation | 3 | 2017 | 8436 | 0.130 |
Why?
|
Movement Disorders | 3 | 2007 | 445 | 0.120 |
Why?
|
Neoplasm Staging | 3 | 2020 | 11031 | 0.120 |
Why?
|
Adaptor Proteins, Vesicular Transport | 2 | 2016 | 315 | 0.120 |
Why?
|
Interleukin-10 | 4 | 2023 | 1200 | 0.120 |
Why?
|
Internal Capsule | 1 | 2015 | 113 | 0.120 |
Why?
|
CA1 Region, Hippocampal | 1 | 2015 | 112 | 0.120 |
Why?
|
Nutritional Status | 1 | 2023 | 1609 | 0.120 |
Why?
|
Renal Artery | 1 | 2016 | 398 | 0.120 |
Why?
|
Rodentia | 1 | 2016 | 261 | 0.120 |
Why?
|
Ribosomal Protein S6 | 1 | 2014 | 70 | 0.120 |
Why?
|
Blood Gas Analysis | 1 | 2015 | 383 | 0.120 |
Why?
|
Genital Diseases, Male | 1 | 2014 | 84 | 0.120 |
Why?
|
Cytokines | 4 | 2021 | 7322 | 0.120 |
Why?
|
Rats, Sprague-Dawley | 8 | 2018 | 8301 | 0.120 |
Why?
|
Kidney Neoplasms | 3 | 2016 | 4262 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 21683 | 0.120 |
Why?
|
Pericytes | 1 | 2016 | 292 | 0.120 |
Why?
|
Cell Transplantation | 1 | 2016 | 477 | 0.120 |
Why?
|
Aged | 13 | 2022 | 163280 | 0.120 |
Why?
|
beta-Alanine | 1 | 2014 | 74 | 0.120 |
Why?
|
Endothelium, Vascular | 4 | 2018 | 4456 | 0.110 |
Why?
|
Female | 27 | 2023 | 380194 | 0.110 |
Why?
|
Carbon Monoxide | 1 | 2016 | 531 | 0.110 |
Why?
|
Long-Term Potentiation | 1 | 2015 | 293 | 0.110 |
Why?
|
Chemotaxis, Leukocyte | 3 | 2002 | 675 | 0.110 |
Why?
|
Leukocytes | 1 | 2021 | 2043 | 0.110 |
Why?
|
Astrocytes | 3 | 2023 | 1270 | 0.110 |
Why?
|
Up-Regulation | 5 | 2019 | 4217 | 0.110 |
Why?
|
Enteric Nervous System | 1 | 2016 | 189 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2014 | 10943 | 0.110 |
Why?
|
Organometallic Compounds | 1 | 2016 | 665 | 0.110 |
Why?
|
Migraine with Aura | 1 | 2015 | 203 | 0.110 |
Why?
|
Interleukin-1beta | 1 | 2018 | 972 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1782 | 0.110 |
Why?
|
Memory Disorders | 3 | 2012 | 1184 | 0.110 |
Why?
|
Lipopolysaccharides | 2 | 2017 | 2216 | 0.110 |
Why?
|
Wound Healing | 2 | 2021 | 2785 | 0.110 |
Why?
|
Visual Cortex | 1 | 2020 | 1149 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 1998 | 1602 | 0.100 |
Why?
|
Blood Platelets | 1 | 2023 | 2508 | 0.100 |
Why?
|
Prostate-Specific Antigen | 2 | 2023 | 2494 | 0.100 |
Why?
|
Middle Aged | 15 | 2023 | 213383 | 0.100 |
Why?
|
United States | 6 | 2023 | 69872 | 0.100 |
Why?
|
Lanatosides | 1 | 2011 | 6 | 0.100 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2014 | 430 | 0.100 |
Why?
|
Tissue Scaffolds | 1 | 2018 | 956 | 0.100 |
Why?
|
Injections, Intraventricular | 1 | 2011 | 230 | 0.100 |
Why?
|
After-Hours Care | 1 | 2012 | 102 | 0.100 |
Why?
|
Hypothermia, Induced | 1 | 1997 | 752 | 0.100 |
Why?
|
Kainic Acid | 1 | 2011 | 199 | 0.100 |
Why?
|
Globins | 1 | 2012 | 415 | 0.100 |
Why?
|
Fibroblast Growth Factors | 1 | 2017 | 879 | 0.100 |
Why?
|
Artificial Limbs | 1 | 2012 | 123 | 0.100 |
Why?
|
Insurance Coverage | 1 | 2022 | 1901 | 0.100 |
Why?
|
Critical Care | 2 | 2015 | 2647 | 0.100 |
Why?
|
Collagenases | 1 | 2011 | 228 | 0.100 |
Why?
|
Reactive Oxygen Species | 3 | 2016 | 2077 | 0.100 |
Why?
|
Postoperative Complications | 3 | 2023 | 15295 | 0.100 |
Why?
|
Urothelium | 1 | 2013 | 277 | 0.100 |
Why?
|
Time Factors | 7 | 2017 | 40075 | 0.090 |
Why?
|
Cultural Evolution | 1 | 2010 | 9 | 0.090 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1678 | 0.090 |
Why?
|
Intracranial Pressure | 2 | 2022 | 326 | 0.090 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 197 | 0.090 |
Why?
|
Sepsis | 2 | 2004 | 2593 | 0.090 |
Why?
|
Spatial Behavior | 1 | 2010 | 90 | 0.090 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1770 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39050 | 0.090 |
Why?
|
Drug Therapy | 1 | 2013 | 497 | 0.090 |
Why?
|
Multiple Trauma | 1 | 2012 | 367 | 0.090 |
Why?
|
Survival Analysis | 3 | 2021 | 10252 | 0.090 |
Why?
|
Cross Infection | 1 | 1999 | 1416 | 0.090 |
Why?
|
Vascular Diseases | 1 | 2018 | 1161 | 0.090 |
Why?
|
Propensity Score | 1 | 2016 | 1781 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5535 | 0.090 |
Why?
|
Medicaid | 1 | 2022 | 2736 | 0.090 |
Why?
|
Chronic Disease | 2 | 2022 | 9146 | 0.090 |
Why?
|
Matrix Metalloproteinases | 1 | 2012 | 391 | 0.090 |
Why?
|
Chromosomes, Human, Y | 1 | 2010 | 148 | 0.090 |
Why?
|
Enzyme Activation | 2 | 2014 | 3701 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6538 | 0.080 |
Why?
|
Body Water | 1 | 2010 | 343 | 0.080 |
Why?
|
Survival Rate | 2 | 2020 | 12788 | 0.080 |
Why?
|
Agriculture | 1 | 2010 | 190 | 0.080 |
Why?
|
Random Allocation | 1 | 2013 | 2429 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2014 | 850 | 0.080 |
Why?
|
Drug Synergism | 2 | 2011 | 1792 | 0.080 |
Why?
|
Cell Line | 2 | 2014 | 15997 | 0.080 |
Why?
|
Oligopeptides | 1 | 2014 | 1189 | 0.080 |
Why?
|
Skin | 1 | 2021 | 4364 | 0.080 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2645 | 0.080 |
Why?
|
Health Care Surveys | 1 | 2015 | 2453 | 0.080 |
Why?
|
Robotics | 1 | 2015 | 899 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 5 | 2023 | 35421 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2017 | 2958 | 0.080 |
Why?
|
Apolipoproteins E | 1 | 2013 | 1438 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1790 | 0.080 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57776 | 0.080 |
Why?
|
Neurology | 1 | 2015 | 763 | 0.070 |
Why?
|
Transfection | 2 | 2014 | 5892 | 0.070 |
Why?
|
Neuregulin-1 | 1 | 2007 | 142 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6895 | 0.070 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1620 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 1613 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1564 | 0.070 |
Why?
|
Neutrophil Infiltration | 2 | 2021 | 390 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2886 | 0.070 |
Why?
|
Antibodies, Blocking | 1 | 2007 | 253 | 0.070 |
Why?
|
Mitochondria | 2 | 2023 | 3520 | 0.070 |
Why?
|
Nuclear Envelope | 1 | 2007 | 172 | 0.070 |
Why?
|
Blood Pressure | 2 | 2015 | 8554 | 0.070 |
Why?
|
Adolescent | 12 | 2024 | 85781 | 0.070 |
Why?
|
Green Fluorescent Proteins | 1 | 2011 | 2088 | 0.070 |
Why?
|
Blood Vessels | 1 | 2012 | 1125 | 0.070 |
Why?
|
Complement Activation | 1 | 2008 | 453 | 0.070 |
Why?
|
Complement C3 | 1 | 2008 | 461 | 0.070 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2005 | 49 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2009 | 638 | 0.070 |
Why?
|
Isomerism | 1 | 2005 | 201 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2015 | 2564 | 0.070 |
Why?
|
Interleukin-6 | 3 | 2023 | 3200 | 0.060 |
Why?
|
Mental Disorders | 2 | 2022 | 6600 | 0.060 |
Why?
|
RNA Interference | 1 | 2014 | 2889 | 0.060 |
Why?
|
Genetics, Population | 1 | 2010 | 934 | 0.060 |
Why?
|
Predictive Value of Tests | 4 | 2023 | 15076 | 0.060 |
Why?
|
Databases, Factual | 2 | 2021 | 7729 | 0.060 |
Why?
|
Area Under Curve | 2 | 2023 | 1654 | 0.060 |
Why?
|
Laser Therapy | 1 | 2011 | 1072 | 0.060 |
Why?
|
Indicators and Reagents | 1 | 2005 | 462 | 0.060 |
Why?
|
Oxidative Stress | 2 | 2014 | 3086 | 0.060 |
Why?
|
Gene Knockdown Techniques | 1 | 2009 | 1655 | 0.060 |
Why?
|
Genotype | 2 | 2010 | 12951 | 0.060 |
Why?
|
Drug Resistance | 1 | 2010 | 1609 | 0.060 |
Why?
|
Immunoblotting | 1 | 2007 | 1682 | 0.060 |
Why?
|
Hemorrhage | 2 | 2014 | 3461 | 0.060 |
Why?
|
Gene Deletion | 1 | 2011 | 2751 | 0.060 |
Why?
|
Incidence | 3 | 2018 | 20947 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2016 | 4462 | 0.060 |
Why?
|
Laparoscopy | 1 | 2015 | 2151 | 0.060 |
Why?
|
Glasgow Coma Scale | 2 | 2022 | 570 | 0.060 |
Why?
|
Injections, Subcutaneous | 1 | 2004 | 666 | 0.060 |
Why?
|
Recombinant Proteins | 2 | 2017 | 6622 | 0.060 |
Why?
|
Infant | 9 | 2012 | 35136 | 0.060 |
Why?
|
Child, Preschool | 10 | 2012 | 41006 | 0.050 |
Why?
|
Seizures | 2 | 2012 | 2859 | 0.050 |
Why?
|
Neurotrophin 3 | 1 | 2002 | 59 | 0.050 |
Why?
|
Child | 11 | 2022 | 77709 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8480 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2005 | 2050 | 0.050 |
Why?
|
NF-kappa B | 1 | 2010 | 2499 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3843 | 0.050 |
Why?
|
Purpura, Thrombocytopenic | 1 | 2021 | 43 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2003 | 599 | 0.050 |
Why?
|
Burns | 1 | 2012 | 1815 | 0.050 |
Why?
|
Bromodeoxyuridine | 2 | 2016 | 322 | 0.050 |
Why?
|
Patient Care Team | 1 | 2012 | 2531 | 0.050 |
Why?
|
Rotarod Performance Test | 1 | 2020 | 64 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2004 | 1590 | 0.050 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2007 | 1504 | 0.050 |
Why?
|
Pediatrics | 1 | 2015 | 3475 | 0.050 |
Why?
|
Iatrogenic Disease | 1 | 2023 | 547 | 0.050 |
Why?
|
Mice, Inbred BALB C | 3 | 2016 | 6386 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2010 | 1916 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2015 | 4371 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2020 | 21746 | 0.040 |
Why?
|
Phenotype | 2 | 2021 | 16365 | 0.040 |
Why?
|
Capillary Permeability | 2 | 2000 | 798 | 0.040 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1999 | 220 | 0.040 |
Why?
|
Motor Cortex | 1 | 2007 | 986 | 0.040 |
Why?
|
Point-of-Care Systems | 2 | 2012 | 1177 | 0.040 |
Why?
|
Immunomodulation | 1 | 2023 | 541 | 0.040 |
Why?
|
Pelvis | 1 | 2023 | 730 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2018 | 2110 | 0.040 |
Why?
|
Meningitis, Aseptic | 1 | 1999 | 58 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 1375 | 0.040 |
Why?
|
Tissue Culture Techniques | 1 | 2020 | 290 | 0.040 |
Why?
|
Brain Damage, Chronic | 1 | 2000 | 265 | 0.040 |
Why?
|
Nerve Degeneration | 1 | 2003 | 748 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 12072 | 0.040 |
Why?
|
Logistic Models | 3 | 2012 | 13408 | 0.040 |
Why?
|
Muscle Cells | 1 | 2019 | 197 | 0.040 |
Why?
|
Zymosan | 1 | 1998 | 124 | 0.040 |
Why?
|
Lactoferrin | 1 | 1999 | 97 | 0.040 |
Why?
|
Bombyx | 1 | 2018 | 55 | 0.040 |
Why?
|
Rectum | 1 | 2023 | 904 | 0.040 |
Why?
|
Risk Factors | 4 | 2021 | 72290 | 0.040 |
Why?
|
Selectins | 1 | 1998 | 102 | 0.040 |
Why?
|
Shock | 1 | 2021 | 318 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2023 | 810 | 0.040 |
Why?
|
Toll-Like Receptors | 1 | 2021 | 592 | 0.040 |
Why?
|
Yersinia | 1 | 2017 | 10 | 0.040 |
Why?
|
Peritonitis | 1 | 2000 | 365 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2010 | 5097 | 0.040 |
Why?
|
Klebsiella | 1 | 2017 | 48 | 0.040 |
Why?
|
Parvalbumins | 1 | 2019 | 250 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2017 | 604 | 0.040 |
Why?
|
Synaptophysin | 1 | 2017 | 141 | 0.040 |
Why?
|
Macrophages, Alveolar | 1 | 2019 | 407 | 0.040 |
Why?
|
Angiopoietin-1 | 1 | 2017 | 114 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2009 | 2737 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2012 | 3143 | 0.040 |
Why?
|
Vasculitis | 1 | 2021 | 519 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12959 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2021 | 737 | 0.040 |
Why?
|
Radiography, Thoracic | 1 | 2003 | 1265 | 0.040 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2017 | 185 | 0.040 |
Why?
|
Constriction | 1 | 2016 | 181 | 0.040 |
Why?
|
HIV Infections | 1 | 2023 | 16718 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2011 | 13033 | 0.040 |
Why?
|
Mice, Obese | 1 | 2017 | 424 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5172 | 0.030 |
Why?
|
Absorbable Implants | 1 | 2018 | 342 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2016 | 10481 | 0.030 |
Why?
|
Exanthema | 1 | 2021 | 501 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2022 | 2187 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2000 | 1525 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2016 | 170 | 0.030 |
Why?
|
Ischemic Attack, Transient | 1 | 2002 | 935 | 0.030 |
Why?
|
Brain Hemorrhage, Traumatic | 1 | 2015 | 18 | 0.030 |
Why?
|
Glioblastoma | 1 | 2011 | 3481 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7181 | 0.030 |
Why?
|
Body Weight | 2 | 2004 | 4669 | 0.030 |
Why?
|
Mutation | 2 | 2017 | 29786 | 0.030 |
Why?
|
Radiation Injuries, Experimental | 1 | 2016 | 91 | 0.030 |
Why?
|
Prospective Studies | 4 | 2022 | 53288 | 0.030 |
Why?
|
HIV | 1 | 2023 | 1604 | 0.030 |
Why?
|
Gram-Negative Bacteria | 1 | 2017 | 270 | 0.030 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2016 | 237 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2007 | 0.030 |
Why?
|
Telemedicine | 1 | 2012 | 2872 | 0.030 |
Why?
|
Neural Inhibition | 1 | 2019 | 602 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2003 | 1364 | 0.030 |
Why?
|
Models, Immunological | 1 | 2017 | 527 | 0.030 |
Why?
|
Long-Term Synaptic Depression | 1 | 2015 | 59 | 0.030 |
Why?
|
Dendritic Spines | 1 | 2016 | 233 | 0.030 |
Why?
|
Genetic Variation | 1 | 2010 | 6544 | 0.030 |
Why?
|
Organ Specificity | 1 | 2019 | 2008 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1738 | 0.030 |
Why?
|
Peritoneum | 1 | 2015 | 228 | 0.030 |
Why?
|
Penile Diseases | 1 | 2014 | 46 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2021 | 3144 | 0.030 |
Why?
|
Adult Stem Cells | 1 | 2016 | 216 | 0.030 |
Why?
|
Epilepsy | 1 | 2010 | 3310 | 0.030 |
Why?
|
Interneurons | 1 | 2019 | 577 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 1999 | 1537 | 0.030 |
Why?
|
Cues | 1 | 1999 | 873 | 0.030 |
Why?
|
Cerebral Ventricles | 1 | 1997 | 544 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 1998 | 977 | 0.030 |
Why?
|
Scrotum | 1 | 2014 | 115 | 0.030 |
Why?
|
Rats, Wistar | 1 | 1998 | 1901 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 23338 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2017 | 565 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2016 | 504 | 0.030 |
Why?
|
Mental Recall | 1 | 2000 | 1205 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 2016 | 916 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1434 | 0.030 |
Why?
|
Wounds, Nonpenetrating | 1 | 2000 | 794 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2015 | 314 | 0.030 |
Why?
|
Frontal Lobe | 1 | 2000 | 1406 | 0.030 |
Why?
|
New York | 1 | 2015 | 886 | 0.030 |
Why?
|
Triazoles | 1 | 1998 | 911 | 0.030 |
Why?
|
Smoke Inhalation Injury | 1 | 2012 | 49 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 627 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2017 | 713 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2017 | 789 | 0.030 |
Why?
|
Protein Binding | 2 | 2021 | 9386 | 0.030 |
Why?
|
Stroke | 1 | 2015 | 9981 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2003 | 2569 | 0.030 |
Why?
|
Rabbits | 1 | 2018 | 4894 | 0.030 |
Why?
|
Blast Injuries | 1 | 2015 | 302 | 0.030 |
Why?
|
Reference Standards | 1 | 2015 | 1025 | 0.030 |
Why?
|
Blood Coagulation Factors | 1 | 2014 | 355 | 0.030 |
Why?
|
Laboratories | 1 | 2015 | 463 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 1999 | 972 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2003 | 25625 | 0.020 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 59 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2002 | 2916 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2018 | 1275 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1708 | 0.020 |
Why?
|
Myelin Sheath | 1 | 2015 | 652 | 0.020 |
Why?
|
Ischemia | 1 | 2019 | 1907 | 0.020 |
Why?
|
Gliosis | 1 | 2011 | 245 | 0.020 |
Why?
|
Neuropeptides | 1 | 2016 | 942 | 0.020 |
Why?
|
Neurotoxins | 1 | 2011 | 237 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1344 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2017 | 1351 | 0.020 |
Why?
|
Shock, Septic | 1 | 1997 | 775 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2012 | 481 | 0.020 |
Why?
|
Gait Disorders, Neurologic | 1 | 2012 | 231 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8949 | 0.020 |
Why?
|
History, Ancient | 1 | 2010 | 212 | 0.020 |
Why?
|
Piracetam | 1 | 2010 | 87 | 0.020 |
Why?
|
Child Abuse | 1 | 1998 | 1030 | 0.020 |
Why?
|
Nitric Oxide | 1 | 1998 | 2132 | 0.020 |
Why?
|
Middle East | 1 | 2010 | 219 | 0.020 |
Why?
|
Quality Control | 1 | 2012 | 841 | 0.020 |
Why?
|
Phenytoin | 1 | 2010 | 197 | 0.020 |
Why?
|
Glucose | 2 | 2017 | 4397 | 0.020 |
Why?
|
Acute Disease | 1 | 2000 | 7149 | 0.020 |
Why?
|
Carbamazepine | 1 | 2010 | 229 | 0.020 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2010 | 141 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 1998 | 1889 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2017 | 1422 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2171 | 0.020 |
Why?
|
Regression Analysis | 1 | 1998 | 6459 | 0.020 |
Why?
|
Amines | 1 | 2010 | 276 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2018 | 1880 | 0.020 |
Why?
|
Hospitalists | 1 | 2012 | 305 | 0.020 |
Why?
|
Italy | 1 | 2010 | 832 | 0.020 |
Why?
|
Fructose | 1 | 2010 | 288 | 0.020 |
Why?
|
Triazines | 1 | 2010 | 315 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2014 | 1127 | 0.020 |
Why?
|
Tyrosine | 1 | 2012 | 1461 | 0.020 |
Why?
|
Pneumonia | 1 | 2019 | 2133 | 0.020 |
Why?
|
Proteins | 2 | 2002 | 6103 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6442 | 0.020 |
Why?
|
Cell Communication | 1 | 2014 | 1621 | 0.020 |
Why?
|
SEER Program | 1 | 2012 | 1508 | 0.020 |
Why?
|
Models, Neurological | 1 | 2015 | 1774 | 0.020 |
Why?
|
Adult | 4 | 2021 | 214055 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1915 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3508 | 0.020 |
Why?
|
Disease Progression | 2 | 2002 | 13284 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17446 | 0.020 |
Why?
|
Culture | 1 | 2010 | 633 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13989 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40561 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3508 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8324 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2011 | 1701 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8089 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2025 | 0.020 |
Why?
|
Mice, Nude | 1 | 2011 | 3689 | 0.020 |
Why?
|
Young Adult | 2 | 2021 | 56430 | 0.020 |
Why?
|
Proteomics | 1 | 2017 | 3638 | 0.010 |
Why?
|
Nerve Growth Factors | 1 | 2007 | 574 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2016 | 11483 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2010 | 1121 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12245 | 0.010 |
Why?
|
Haplotypes | 1 | 2010 | 2779 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2017 | 3864 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9438 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3339 | 0.010 |
Why?
|
Electroencephalography | 1 | 1998 | 6150 | 0.010 |
Why?
|
Autophagy | 1 | 2011 | 1300 | 0.010 |
Why?
|
Computational Biology | 1 | 2015 | 3521 | 0.010 |
Why?
|
Gene Transfer, Horizontal | 1 | 2003 | 145 | 0.010 |
Why?
|
Anxiety | 1 | 2017 | 4297 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 2003 | 449 | 0.010 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2002 | 27 | 0.010 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2002 | 48 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 2208 | 0.010 |
Why?
|
Public Health | 1 | 2015 | 2603 | 0.010 |
Why?
|
Receptor, trkC | 1 | 2002 | 68 | 0.010 |
Why?
|
Mice, Neurologic Mutants | 1 | 2002 | 126 | 0.010 |
Why?
|
Enzyme Precursors | 1 | 2002 | 176 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6309 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2759 | 0.010 |
Why?
|
Free Radicals | 1 | 2002 | 237 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2002 | 216 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5853 | 0.010 |
Why?
|
Radiography | 1 | 2012 | 7023 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2002 | 829 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 5985 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8642 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2003 | 20129 | 0.010 |
Why?
|
Defensins | 1 | 1999 | 35 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1454 | 0.010 |
Why?
|
Critical Illness | 1 | 2012 | 2670 | 0.010 |
Why?
|
Pennsylvania | 1 | 2000 | 613 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9648 | 0.010 |
Why?
|
Microsomes, Liver | 1 | 1998 | 173 | 0.010 |
Why?
|
Nitrites | 1 | 1998 | 160 | 0.010 |
Why?
|
Neutrophil Activation | 1 | 1999 | 186 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12354 | 0.010 |
Why?
|
Communication | 1 | 2012 | 3749 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11727 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10397 | 0.010 |
Why?
|
Nitrates | 1 | 1998 | 265 | 0.010 |
Why?
|
Nucleosomes | 1 | 2000 | 494 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7186 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 1998 | 1105 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15165 | 0.010 |
Why?
|
Organ Size | 1 | 1998 | 2252 | 0.010 |
Why?
|
Temporal Lobe | 1 | 2000 | 1670 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2002 | 3420 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1998 | 2726 | 0.010 |
Why?
|
Depression | 1 | 2011 | 7766 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2002 | 3768 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 15519 | 0.010 |
Why?
|
Oxygen | 1 | 2002 | 4189 | 0.010 |
Why?
|
Linear Models | 1 | 2000 | 5952 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2011 | 8863 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2002 | 5021 | 0.010 |
Why?
|
Age Factors | 1 | 2000 | 18370 | 0.000 |
Why?
|